证券之星消息，11月24日专业连锁板块较上一交易日上涨1.97%，华致酒行领涨。当日上证指数报收于 3836.77，上涨0.05%。深证成指报收于12585.08，上涨0.37%。专业连锁板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300755 | 华致酒行 | 18.98 | 3.60% | 6.42万 | | 1.22亿 | | 000829 | 天音控股 | 10.44 | 3.47% | 25.80万 | | 2.671Z | | 300622 | 博士眼镜 | 28.93 | 2.63% | 8.52万 | | 2.42亿 | | 002416 | 爰施德 | 11.75 | 1.47% | 14.60万 | | 1.71亿 | | 301078 | 孩子王 | 10.00 | 1.11% | 16.62万 | | 1.65亿 | | 300022 | 吉峰科技 | 8.35 | 0.36% | 10.15万 | | 8523.07万 | | ...

Core Insights - The professional chain sector experienced a decline of 2.94% on November 21, with Doctor Glasses leading the drop [1] - The Shanghai Composite Index closed at 3834.89, down 2.45%, while the Shenzhen Component Index closed at 12538.07, down 3.41% [1] Market Performance - The closing prices and changes for key stocks in the professional chain sector are as follows: - Jifeng Technology: 8.32, -0.12% - Anyin Holdings: 10.09, -0.59% - Yashide: 11.58, -2.03% - Aiyingshi: 17.10, -4.36% - Huazhi Wine: 18.32, -4.43% - Haiziwang: 9.89, -4.63% - Doctor Glasses: 28.19, -5.47% [1] Capital Flow - The professional chain sector saw a net outflow of 155 million yuan from main funds, while retail investors contributed a net inflow of 152 million yuan [1] - The detailed capital flow for specific stocks indicates: - Huazhi Wine: Main funds net inflow of 177,900 yuan, retail net inflow of 3.18 million yuan - Jifeng Technology: Main funds net outflow of 364,200 yuan, retail net outflow of 12.14 million yuan - Anyin Holdings: Main funds net outflow of 5.54 million yuan, retail net inflow of 684,600 yuan - Aiyingshi: Main funds net outflow of 7.79 million yuan, retail net inflow of 8.49 million yuan - Yashide: Main funds net outflow of 26.25 million yuan, retail net inflow of 28.43 million yuan - Doctor Glasses: Main funds net outflow of 34.83 million yuan, retail net inflow of 52.55 million yuan - Haiziwang: Main funds net outflow of 80.41 million yuan, retail net inflow of 70.49 million yuan [2]

天音控股晚间公告，公司于近日收到中国证券监督管理委员会出具的《关于同意天音通信控股股份有限 公司向特定对象发行股票注册的批复》。证监会同意公司向特定对象发行股票的注册申请。本批复自同 意注册之日起12个月内有效。公司董事会将根据上述文件和相关法律、法规的要求及公司股东会的授 权，在规定期限内办理本次向特定对象发行股票相关事宜，并及时履行信息披露义务。敬请广大投资者 注意投资风险。 （文章来源：第一财经） ...

保荐人（主承销商） 广东省深圳市福田区中心三路8号卓越时代广场（二期）北座 二零二五年十月 天音通信控股股份有限公司 2023年度向特定对象发行A股股票募集说明书 声 明 本公司及全体董事、监事、高级管理人员承诺本募集说明书内容真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，按照诚信原则履行承诺，并承担相应的法律责任。 中国证监会、深圳证券交易所对本次发行所作的任何决定或意见，均不表明其对申请文件及所披露信息 的真实性、准确性、完整性作出保证，也不表明其对公司的盈利能力、投资价值或者对投资者的收益作 出实质性判断或保证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，公司经营与收益的变化，由公司自行负责。投资者自主判断 公司的投资价值，自主作出投资决策，自行承担证券依法发行后因公司经营与收益变化或者证券价格变 动引致的投资风险。 本募集说明书所述事项并不代表审批机关对于本次发行相关事项的实质性判断、确认、批准或注册，本 募集说明书所述本次发行相关事项的生效和完成尚需中国证监会注册批复文件。 重大事项提示 公司特别提示投资者注意，在作出投资决策之前，务必仔细阅读本募集说明书 ...

截至2025年11月19日收盘，天音控股（000829）报收于10.09元，较前一交易日下跌0.88%，最新总市值 为103.43亿元。该股当日开盘10.17元，最高10.23元，最低10.02元，成交额达1.16亿元，换手率为 1.12%。 公司近日发布公告称，天音通信控股股份有限公司于近日收到中国证监会出具的《关于同意天音通信控 股股份有限公司向特定对象发行股票注册的批复》（证监许可〔2025〕2526号），核准公司向特定对象 发行股票的注册申请。批复自同意注册之日起12个月内有效。公司需严格按照报送深圳证券交易所的申 报文件和发行方案实施发行，并在发生重大事项时及时报告。董事会将根据批复要求及股东会授权，在 规定期限内办理相关事宜并履行信息披露义务。 最新公告列表 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 《关于向特定对象发行股票申请获得中国证监会同意注册批复的公告》 《天音通信控股股份有限公司2023年度向特定对象发行A股股票募集说明书（注册稿）》 ...

证券日报网讯 11月19日晚间，天音控股发布公告称，公司于近日收到中国证券监督管理委员会（简 称"中国证监会"）出具的《关于同意天音通信控股股份有限公司向特定对象发行股票注册的批复》（证 监许可〔2025〕2526号），批复的主要内容如下：一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送深圳证券交易所的申报文件和发行方案实施。三、本批复自同意注 册之日起12个月内有效。四、自同意注册之日起至本次发行结束前，你公司如发生重大事项，应及时报 告深圳证券交易所并按有关规定处理。 （文章来源：证券日报） ...

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

天音控股(000829.SZ)公告称，公司于近日收到中国证券监督管理委员会出具的《关于同意天音通信控 股股份有限公司向特定对象发行股票注册的批复》。证监会同意公司向特定对象发行股票的注册申请。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

天音控股（000829）(000829.SZ)公告，公司近日收到中国证券监督管理委员会出具的《关于同意天音 通信控股股份有限公司向特定对象发行股票注册的批复》，同意公司向特定对象发行股票的注册申请。 ...

天音通信控股股份有限公司（以下简称"公司"）于近日收到中国证券监督管 理委员会（以下简称"中国证监会"）出具的《关于同意天音通信控股股份有限公 司向特定对象发行股票注册的批复》（证监许可〔2025〕2526 号），批复的主 要内容如下： 一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送深圳证券交易所的申报文件和发行方案 实施。 证券简称：天音控股 证券代码：000829 公告编号：2025-053 号 天音通信控股股份有限公司 关于向特定对象发行股票申请获得中国证监会 同意注册批复的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 董 事 会 本次向特定对象发行股票的发行人和保荐人的联系方式如下： 一、发行人：天音通信控股股份有限公司 1、联系部门：证券部 2、联系电话：010-58300807 3、电子邮箱：ir@chinatelling.com 二、保荐人（主承销商）：中信证券股份有限公司 1、保荐代表人：丁潮钦、吴曦 2、联系部门：股票资本市场部 3、联系电话：0755-23835185、010-60833089 4、电 ...